GATINEAU, QC, Aug. 18 /CNW Telbec/ - ImaSight Corp. (IAS:TSX-V) announced today that its Liponex division has filed for patent protection of a novel discovery related to its cardiovascular technology and initiated discussions with three companies that have expressed an interest in acquiring the Liponex technology.
